User login
1. Which of the following chemotherapy agents has demonstrated the ability to cause accelerated rheumatoid nodule formation?
a. cisplatin
b. methotrexate
c. paclitaxel
d. rituximab
e. tamoxifen
2. Which of the following chemotherapy agents can cause sticky skin syndrome when combined with ketoconazole?
a. doxorubicin
b. etoposide
c. imatinib
d. sorafenib
e. thalidomide
3. Which of the following agents is not a protein kinase inhibitor?
a. bortezomib
b. cetuximab
c. erlotinib
d. imatinib
e. sorafenib
4. Which of the following chemotherapy agents can be used off label in the treatment of dermatofibrosarcoma protuberans?
a. etoposide
b. imatinib
c. interferon alfa
d. lenalidomide
e. methotrexate
5. What chemotherapy agent has been shown to cause deep venous thromboembolism?
a. daunorubicin
b. doxorubicin
c. erlotinib
d. paclitaxel
e. thalidomide
1. Which of the following chemotherapy agents has demonstrated the ability to cause accelerated rheumatoid nodule formation?
a. cisplatin
b. methotrexate
c. paclitaxel
d. rituximab
e. tamoxifen
2. Which of the following chemotherapy agents can cause sticky skin syndrome when combined with ketoconazole?
a. doxorubicin
b. etoposide
c. imatinib
d. sorafenib
e. thalidomide
3. Which of the following agents is not a protein kinase inhibitor?
a. bortezomib
b. cetuximab
c. erlotinib
d. imatinib
e. sorafenib
4. Which of the following chemotherapy agents can be used off label in the treatment of dermatofibrosarcoma protuberans?
a. etoposide
b. imatinib
c. interferon alfa
d. lenalidomide
e. methotrexate
5. What chemotherapy agent has been shown to cause deep venous thromboembolism?
a. daunorubicin
b. doxorubicin
c. erlotinib
d. paclitaxel
e. thalidomide
1. Which of the following chemotherapy agents has demonstrated the ability to cause accelerated rheumatoid nodule formation?
a. cisplatin
b. methotrexate
c. paclitaxel
d. rituximab
e. tamoxifen
2. Which of the following chemotherapy agents can cause sticky skin syndrome when combined with ketoconazole?
a. doxorubicin
b. etoposide
c. imatinib
d. sorafenib
e. thalidomide
3. Which of the following agents is not a protein kinase inhibitor?
a. bortezomib
b. cetuximab
c. erlotinib
d. imatinib
e. sorafenib
4. Which of the following chemotherapy agents can be used off label in the treatment of dermatofibrosarcoma protuberans?
a. etoposide
b. imatinib
c. interferon alfa
d. lenalidomide
e. methotrexate
5. What chemotherapy agent has been shown to cause deep venous thromboembolism?
a. daunorubicin
b. doxorubicin
c. erlotinib
d. paclitaxel
e. thalidomide